glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Oncology Letters
Oncology Letters Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer Communications Biology Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer The role of ERBB4 mutations in the prognosis of advanced non small cell lung cancer treated with immune checkpoint inhibitors Molecular Medicine Springer Nature Link
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




